Evaluating Lorcaserin Drug Therapy For ICU-Acquired Weakness: A Pilot Randomized Trial
Phase of Trial: Phase I/II
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Lorcaserin (Primary) ; Lorcaserin (Primary)
- Indications Muscle weakness
- Focus Therapeutic Use
- Acronyms EMILI
- 29 Aug 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2017.
- 15 Oct 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 21 Aug 2015 New trial record